openPR Logo
Press release

Immunoglobulin Market Forecast: 7.1% CAGR to 2035

12-31-2025 11:22 AM CET | Health & Medicine

Press release from: Expert Market Research

Is the Rising Burden of Immune Disorders Fueling the Global Immunoglobulin Market?

Why Immunoglobulin Therapies Are Gaining Global Importance

Immunoglobulins, commonly referred to as antibodies, are essential components of the human immune system. Derived primarily from human plasma, immunoglobulin therapies are widely used to treat a broad spectrum of immune deficiencies, autoimmune disorders, and inflammatory conditions. Over the past decade, the increasing prevalence of immune-related diseases, improved diagnostic capabilities, and growing awareness of plasma-derived therapies have significantly boosted market demand.

The global immunoglobulin market attained a value of approximately USD 15.66 Billion in 2025 and is expected to grow at a CAGR of 7.10% from 2026 to 2035, reaching nearly USD 31.09 Billion by 2035. This steady expansion reflects the critical role of immunoglobulin therapies in both acute and chronic disease management, particularly in neurology, hematology, and immunology.

Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/immunoglobulin-market/requestsample.

Immunoglobulin Market Overview

The immunoglobulin market comprises plasma-derived products that deliver concentrated antibodies to patients with deficient or dysfunctional immune systems. These therapies can be administered intravenously (IVIG) or subcutaneously (SCIG), depending on the indication and patient needs.

Key Market Highlights

Market Size (2025): USD 15.66 Billion

Forecast Market Size (2035): USD 31.09 Billion

CAGR (2026-2035): 7.10%

Primary Growth Drivers: Rising prevalence of immune disorders, expanding therapeutic applications

Major Product Types: IVIG and SCIG

The market is characterized by high entry barriers due to complex plasma collection, fractionation processes, and stringent regulatory requirements.

What Is Driving Growth in the Immunoglobulin Market?

Immunoglobulin therapies have transitioned from niche treatments to standard-of-care solutions for many rare and chronic conditions. Their immunomodulatory effects, combined with a strong safety profile, have supported widespread adoption across healthcare systems.

Key factors contributing to market growth include increasing diagnosis of immune disorders, aging populations, and expanded off-label use in neurological and autoimmune diseases.

Key Growth Drivers of the Immunoglobulin Market

1. Rising Prevalence of Immunodeficiency Diseases

Primary and secondary immunodeficiency disorders are being diagnosed more frequently due to better screening and awareness, directly increasing demand for immunoglobulin therapies.

2. Growing Use in Neurological Disorders

Conditions such as CIDP, Guillain-Barré syndrome, multifocal motor neuropathy, and myasthenia gravis are major drivers of IVIG demand.

3. Aging Global Population

Older populations are more susceptible to immune dysfunction, chronic inflammatory conditions, and hematological malignancies, supporting long-term market growth.

4. Expansion of Plasma Collection Infrastructure

Investments in plasma donation centers and fractionation facilities are improving product availability, particularly in developed markets.

5. Improved Reimbursement and Access

Favorable reimbursement frameworks in North America and Europe have enhanced patient access to immunoglobulin therapies.

Emerging Trends in the Immunoglobulin Market

Shift Toward Subcutaneous Immunoglobulin (SCIG)

SCIG is gaining popularity due to its convenience, reduced hospital visits, and improved quality of life for patients requiring long-term therapy.

Growth in Home-Based Treatment

Home infusion and self-administration models are becoming more common, particularly for chronic immunodeficiency patients.

Advancements in Plasma Fractionation Technology

Improved manufacturing processes are enhancing yield, safety, and scalability.

Rising Demand in Emerging Markets

Asia Pacific and Latin America are witnessing increased adoption due to improved healthcare infrastructure and diagnosis rates.

Focus on Supply Chain Security

Manufacturers are prioritizing plasma supply resilience to address chronic shortages.

Market Segmentation Analysis

By Application

Immunoglobulin therapies are used across a wide range of indications, many of which are chronic and require lifelong treatment.

Hypogammaglobulinemia: Largest application segment, driven by primary immunodeficiency cases

CIDP (Chronic Inflammatory Demyelinating Polyneuropathy): Significant neurological application

Immunodeficiency Diseases: Includes primary and secondary immune deficiencies

Congenital AIDS: Supportive therapy to prevent infections

Chronic Lymphocytic Leukaemia: Used to manage secondary immunodeficiency

Myasthenia Gravis: Effective immunomodulatory treatment

Multifocal Motor Neuropathy: High IVIG dependency

ITP (Immune Thrombocytopenic Purpura): Acute and chronic management

Kawasaki Disease: Pediatric indication with strong clinical evidence

Guillain-Barré Syndrome: Critical acute neurological application

By Route of Administration

Intravenous Immunoglobulin (IVIG)

Dominates market share

Preferred for acute and severe conditions

Administered in hospitals and specialty clinics

Subcutaneous Immunoglobulin (SCIG)

Fastest-growing segment

Suitable for long-term therapy

Enables home-based administration

By Clinical Trial Category

IgG

Most widely used and studied

Accounts for the majority of therapeutic applications

IgA

Limited use due to risk of allergic reactions

Used in specific research settings

IgM

Investigated for enhanced immune response

Growing interest in acute infection management

IgE

Primarily used in allergy research and diagnostics

IgD

Least understood, limited therapeutic use

Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/immunoglobulin-market.

Regional Analysis of the Immunoglobulin Market

North America

Largest regional market

High diagnosis rates and strong reimbursement systems

Significant plasma collection infrastructure

Europe

Mature market with strong regulatory oversight

High adoption in neurology and immunology

Asia Pacific

Fastest-growing region

Rising healthcare investments and awareness

Expanding plasma fractionation capacity

Latin America

Gradual market expansion

Improving access to specialty therapies

Middle East and Africa

Emerging market

Limited plasma infrastructure but growing demand

Competitive Landscape of the Immunoglobulin Market

The immunoglobulin market is highly consolidated due to high capital requirements and regulatory complexity.

Companies Covered

Biotest AG

Octapharma AG

Baxter International Inc.

China Biologics Products Inc.

Grifols SA

Key Competitive Strategies

Expansion of plasma donation networks

Investment in manufacturing capacity

Strategic acquisitions and partnerships

Focus on high-growth emerging markets

Challenges Facing the Immunoglobulin Market

Despite strong demand, the market faces several challenges:

Chronic plasma supply shortages

High treatment costs

Complex manufacturing processes

Stringent regulatory requirements

Limited access in low-income regions

Addressing these challenges is essential to ensure sustainable market growth.

Future Outlook of the Immunoglobulin Market (2026-2035)

The immunoglobulin market is expected to maintain steady growth over the next decade. By 2035, the market is projected to reach USD 31.09 Billion, supported by:

Increasing prevalence of immune and neurological disorders

Continued shift toward SCIG

Expansion of plasma collection infrastructure

Growth in emerging healthcare markets

Ongoing clinical research into new indications

Immunoglobulin therapies will remain a cornerstone of immune disease management worldwide.

Browse More Reports

United States Topical Pain Relief Market - https://bit.ly/43Fje4N.

Cough Syrup Market - https://bit.ly/4oRldLU.

Emergency Medical Services (EMS) Vehicle Market - https://bit.ly/3JwPrV9.

India Biosimilar Market - https://bit.ly/4oX4xT4.

Media Contact

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunoglobulin Market Forecast: 7.1% CAGR to 2035 here

News-ID: 4333430 • Views:

More Releases from Expert Market Research

Dental Tourism Market to Reach USD 42.57B by 2035 at 16.8% CAGR
Dental Tourism Market to Reach USD 42.57B by 2035 at 16.8% CAGR
Is Affordable, High-Quality Care Driving the Global Dental Tourism Market Boom? Why Dental Tourism Is Transforming Global Oral Healthcare In recent years, the Dental Tourism Market has emerged as one of the fastest-growing segments within the global medical tourism industry. Rising dental care costs in developed countries, long waiting times, and limited insurance coverage have prompted millions of patients to seek cost-effective, high-quality dental treatments abroad. Coupled with rapid technological advancements, internationally
Medical Supply Delivery Service Market Growth to USD 162.51B by 2035
Medical Supply Delivery Service Market Growth to USD 162.51B by 2035
Can Faster, Smarter Logistics Transform the Global Medical Supply Delivery Service Market? Why Medical Supply Delivery Services Are Becoming Mission-Critical Timely access to medicines, medical devices, diagnostic samples, and emergency supplies can be the difference between life and death. As healthcare systems worldwide face growing patient volumes, aging populations, and rising expectations for speed and reliability, the Medical Supply Delivery Service Market has emerged as a critical backbone of modern healthcare infrastructure. From
AI-Based Fever Detection Camera Market: USD 1.89B in 2025, CAGR 8.1%
AI-Based Fever Detection Camera Market: USD 1.89B in 2025, CAGR 8.1%
Can AI-Based Fever Detection Cameras Redefine Public Health Surveillance Worldwide? The Rise of Intelligent Fever Screening Systems The global healthcare and security ecosystem is undergoing a rapid digital transformation, fueled by artificial intelligence (AI), computer vision, and automation. Among the most impactful innovations to emerge in recent years are AI-based fever detection cameras, which enable fast, contactless, and large-scale temperature screening in public and private spaces. Initially gaining prominence during global health emergencies,
Brazil Shock Wave Therapy Devices Market Worth USD 336.36M by 2035
Brazil Shock Wave Therapy Devices Market Worth USD 336.36M by 2035
Is Shock Wave Therapy Transforming Non-Invasive Treatment in Brazil's Healthcare System? Why the Brazil Shock Wave Therapy Devices Market Is Gaining Momentum Brazil's healthcare landscape is undergoing a steady transformation, driven by rising chronic conditions, sports-related injuries, an aging population, and growing preference for non-invasive and minimally invasive therapies. Among the technologies benefiting from these trends is shock wave therapy, a clinically proven modality used across orthopedics, urology, cardiology, sports medicine, and

All 5 Releases


More Releases for Immunoglobulin

Immunoglobulin Market Forecast 2035 | Advancing Therapeutic Outcomes: Growth of …
An extensive study of propelling opportunities in, "Immunoglobulin Market Size, Share & Trends Analysis Report by Product Type (IgG, IgA, IgM, IgE, IgD), Form, Route of Administration, Application, Source, Technology, Therapy Type, Patient Demographics, End-user / Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) - Global Industry Data, Trends, and Forecasts, 2025-2035" A comprehensive report of growing market landscapes in the immunoglobulin sector
Rabies Immunoglobulin Market - Dynamics and Growth Pattern
The "Rabies Immunoglobulin Market" forecast 2031 report analyses the present and future competitive scenario of the analytics industry. Rabies Immunoglobulin Market report offers an in-depth analysis on segments including top companies, products, applications, revenue and regions. a number of topics including likewise market share, drivers, trends and methods. This report additionally offers insights into the latest growth and trends. It encapsulates key aspects of the market, with focus on leading
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements …
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate? There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of